Skip to main navigation Skip to search Skip to main content

A randomised placebo-controlled study examining the role of anti-IgE in severe recalcitrant paediatric atopic eczema: the Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT)

Project: Research

Project Details

StatusFinished
Effective start/end date1/12/2011 → 31/01/2018

Collaborative partners

Funding

  • NIHR National Institute For Health & Care Research: £478,697.00